Understand the signs of premature ovarian failure and POI. Learn how to manage symptoms and protect your long-term health.
Preview this article 1 min In ovarian cancer alone — the fifth-most common cause of death in women — Lifyorli could ring up ...
Landmark tumour mapping research could boost targeted breast and ovarian cancer therapies - The researchers said the findings ...
Investigators compared mortality risk among long-term survivors of high-grade serous ovarian cancer versus the general US population to examine how mortality and recurrence trends have changed with ...
Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
The FDA has given the all-clear to Corcept’s class-first Lifyorli (relacorilant) to treat adults with platinum-resistant ...
It's Ovarian Cancer Month, and Catherine is recovering after undergoing chemotherapy and surgery to treat stage 3 cancer ...
Scientists have for the first time decoded the full range of mutations that drive tumour growth. | ITV News Granada ...
Telmisartan, an FDA-approved blood pressure drug, could boost a certain cancer treatment's effectiveness against tumors, a ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
It’s easy to brush off abdominal discomfort and changes in bowel habits as a normal part of menopause, but it’s important to listen to your body and to not ignore any persistent or unusual symptoms.
He called and he said, ‘I’ve got the CT scan results, and it’s not diverticulitis, it’s cancer,’” Barr said, adding the scan ...
A self-acupressure app helped nearly 60% of women with ovarian cancer no longer experience cancer-related fatigue.The MeTime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results